Kidswell Bio Corp.

70
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3386460004
JPY
211.00
-8 (-3.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Kidswell Bio Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
72.00
-1,420.00
-656.00
-549.00
-999.00
-7,314.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
897.00
911.00
-824.00
-225.00
-274.00
-154.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
936.00
-453.00
-1,421.00
-1,169.00
-1,267.00
-1,325.00
Cash Flow from Investing Activities
65.00
0.00
-28.00
526.00
-22.00
-137.00
Cash Flow from Financing Activities
-240.00
1,617.00
1,356.00
369.00
718.00
1,221.00
Net Cash Inflow / Outflow
761.00
1,164.00
-93.00
-273.00
-571.00
-240.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kidswell Bio Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
72.867
-869.747
941.00
108.38%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
897.505
-11.427
908.00
7954.25%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
936.707
-760.553
1,696.00
223.16%
Cash Flow from Investing Activities
65.077
-8.637
73.00
853.47%
Cash Flow from Financing Activities
-240.061
-52.012
-188.00
-361.55%
Net Cash Inflow / Outflow
761.723
-821.202
1,582.00
192.76%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 306.49% vs 68.08% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
936.71
-453.63
306.49%